ロード中...
Overcoming resistance to immunotherapy by teaching old drugs new tricks
Cancer stem cells (CSCs) underlie resistance to therapy. Cancer develops only in the context of failing immunosurveillance, and stem cells occupy immune privileged microenvironments. Recent evidence demonstrates that CSCs borrow immune privilege from their normal counterparts. However, low doses of...
保存先:
| 出版年: | Mol Cell Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469442/ https://ncbi.nlm.nih.gov/pubmed/32944648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1801088 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|